Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects-Reference-Cited by-同舟云学术

Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects

Published:2016-02 Issue:2 Volume:65 Page:1-11
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Tanaka Masashi,Matsuo Yoshiyuki,Yamakage Hajime,Masuda Shinya,Terada Yuko,Muranaka Kazuya,Wada Hiromichi,Hasegawa Koji,Shimatsu Akira,Satoh-Asahara Noriko

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab,2013

2. Cardiovascular biology of the incretin system;Ussher;Endocr Rev,2012

3. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4;Arakawa;Diabetes,2010

4. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis;Shah;Circulation,2011

5. Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice;Vittone;Diabetologia,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes;Frontiers in Immunology;2024-08-01

2. GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage;American Journal of Physiology-Heart and Circulatory Physiology;2024-05-01

3. Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process;International Journal of Molecular Sciences;2024-02-03

4. Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets;International Journal of Molecular Sciences;2023-06-15

5. Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes;Biomedicines;2023-05-04